Hint mode is switched on Switch off

Rigel Pharmaceuticals, ordinary share
RIGL, US7665596034

Add a stock to WL
Choose all Reset all
Rigel Pharmaceuticals, сountry — USA
27/06/2024 stock stopped trading due to affiliation to Rigel Pharmaceuticals, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Rigel Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RIGL
  • Placement
    31.01.2017
  • Lock up period
    180
  • Number of papers
    20,000,000
  • Volume of raised funds
    40 mln USD
  • Placement share
    16.82%
  • Final placement price
    2 USD
  • Price change since placement date
    -100%
  • By capitalization
    237.82 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RIGL
  • Placement
    18.04.2018
  • Lock up period
    180
  • Number of papers
    15,000,000
  • Volume of raised funds
    61.65 mln USD
  • Placement share
    9.27%
  • Final placement price
    4.11 USD
  • Price change since placement date
    -100%
  • By capitalization
    665.06 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

25/06/2026 Rigel Pharmaceuticals: Item 5.02 — Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
11/06/2026 Rigel Pharmaceuticals: Completion Of Acquisition Or Disposition Of Assets
11/05/2026 Rigel Pharmaceuticals: Entry Into A Material Definitive Agreement
16/04/2026 Rigel Pharmaceuticals: Termination Of A Material Definitive Agreement
12/01/2026 Rigel Pharmaceuticals: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.